Publications

COVID-19 Vaccine Decision-making Factors in Racial and Ethnic Minority Communities in Los Angeles, California

Accuracy of Asthma Computable Phenotypes to Identify Pediatric Asthma at an Academic Institution

Guidelines

HOW TO CITE INSTITUTE FOR PRECISION HEALTH IN PUBLICATIONS

The sample and data gathered from UCLA ATLAS Community Health Initiative patients represent an unprecedented resource for genetic studies. Therefore, we require that researchers who receive financial support or utilize supported resources or services from the Institute for Precision Health (IPH) acknowledge IPH appropriately.

To this end, we have created the following guidelines for citing IPH. If you need further clarification, please contact IPH Sr. Program Manager, Maryam Ariannejad at Precision Medicine.

1. If researchers used UCLA ATLAS Community Health Initiative biomaterials or accessed the genotypic or phenotypic data, UCLA ATLAS Community Health Initiative and IPH should be acknowledged as follows:

• Use of patient clinical data collected during clinical care (e.g., EHR/DDR, PACS etc.) requires acknowledgement of the clinical resource that was used. DDR reference as of 1/24/2022 should cite:

Chang TS, Ding Y, Freund MK, Johnson R, Schwarz T, Yabu JM, Hazlett C, Chiang JN, Wulf DA; UCLA Precision Health Data Discovery Repository Working Group, Geschwind DH, Butte MJ, Pasaniuc B. Pre-existing conditions in Hispanics/Latinxs that are COVID-19 risk factors. iScience. 2021 Mar 19;24(3):102188. doi: 10.1016/j.isci.2021.102188 : https://doi.org/10.1016/j.isci.2021.102188. Epub 2021 Feb 12.PMID: 33615196

• Use of data generated using clinical patient data from the ATLAS biobank should cite:

Lajonchere C, Naeim A, Dry S, Wenger N, Elashoff D, Vangala S, Petruse A, Ariannejad M, Magyar C, Johansen L, Werre G, Kroloff M, Geschwind D, An Integrated, Scalable, Electronic Video Consent Process to Power Precision Health Research: Large, Population-Based, Cohort Implementation and Scalability Study. J Med Internet Res 2021;23(12):e31121; doi: 10.2196/31121 : https://www.jmir.org/2021/12/e31121 

• Researchers accessing SNP array data from patients in the ATLAS biobank (non-Regeneron) as of 1/24/2022 should cite the below preprint:

Leveraging genomic diversity for discovery in an EHR-linked biobank: the UCLA ATLAS Community Health Initiative. Ruth Johnson, Yi Ding, Vidhya Venkateswaran, Arjun Bhattacharya, Alec Chiu, Tommer Schwarz, Malika Freund, Lingyu Zhan, Kathryn S. Burch, Christa Caggiano, Brian Hill, Nadav Rakocz, Brunilda Balliu, Jae Hoon Sul, Noah Zaitlen, Valerie A. Arboleda, Eran Halperin, Sriram Sankararaman, Manish J. Butte, UCLA Precision Health Data Discovery Repository Working Group, UCLA Precision Health ATLAS Working Group, Clara Lajonchere, Daniel H. Geschwind, Bogdan Pasaniuc

medRxiv 2021.09.22.21263987; doi: https://doi.org/10.1101/2021.09.22.21263987 

•  For any WES data generated under the agreement with Regeneron, there are pre-publication review requirements that must be conducted prior to initial submission. Please check with IPH operations leadership, Maryam Ariannejad, to ensure that proper procedures for review and citation are followed.
•  Additionally, please include the following acknowledgement in all papers and publications using data or samples from the ATLAS Precision Health Biobank:

"We gratefully acknowledge the Institute for Precision Health, participating patients from the UCLA ATLAS Precision Health Biobank, UCLA David Geffen School of Medicine, UCLA Clinical and Translational Science Institute, and UCLA Health.”

2. IPH faculty that receive financial support or utilize supported resources or services from the Institute for Precision Health are required to include their IPH affiliation in grants, presentation, and other media.

3. Any researcher that publishes a manuscript based on IPH data or resources should forward a link to: Maryam Ariannejad, IPH Sr. Program Manager - Precision Medicine.